Kharkiv National Medical University, formerly known as Kharkiv Medical Institute and previously Kharkiv State Medical University, is a medical university in Kharkiv, Ukraine. In March 2022 many buildings were heavily damaged due to the Russian invasion into Ukraine.

During the past decade, Kharkiv Regional Clinical Children's Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kharkiv Regional Clinical Children's Hospital" #1 sponsor was "GlaxoSmithKline" with 2 trials, followed by "Takeda" with 2 trials sponsored, "Ascendis Pharma A/S" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Ferring Pharmaceuticals" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kharkiv Regional Clinical Children's Hospital" #1 collaborator was "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Bausch Health Americas, Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Ludwig-Maximilians - University of Munich" with 1 trials as a collaborator and "University College, London" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Kharkiv Regional Clinical Children's Hospital" are "Crohn's Disease" (2 trials), "Hepatitis B" (2 trials), "Ulcerative Colitis" (2 trials), "AIDS" (1 trials) and "Acidosis, Lactic" (1 trials). Many other conditions were trialed in "Kharkiv Regional Clinical Children's Hospital" in a lesser frequency.

Most popular intervention types in "Kharkiv Regional Clinical Children's Hospital" are "Drug" (10 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Vedolizumab" (2 trials), "ACP-001" (1 trials), "Genotropin" (1 trials) and "Human Growth Hormone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kharkiv Regional Clinical Children's Hospital" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Kharkiv Regional Clinical Children's Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Kharkiv Regional Clinical Children's Hospital, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kharkiv Regional Clinical Children's Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".